Form C-AR — Deverra Therapeutics, Inc.
0001822782-26-000003 · filed 2026-05-06
Offering
- Target
- —
- Maximum
- —
- Security type
- —
- Price per security
- —
- Deadline
- —
- Oversubscription
- —
Issuer
- CIK
- 1822782
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 2033 6th Ave Suite 600
Seattle, WA 28121 - Phone
- —
Most recent fiscal year financials
View original on SEC EDGAR.